Through RNAseq database searches, we investigated the magnitude of expression of the genes involved in adenosinergic pathway, namely, CD39 (ENTPD1 gene), CD73 (NT5E gene), and CD38 (also responsible for eADO generation) among female HER2+ cancers (Figure 1a). The gene discussed is ERBB2; the disease is cancer.